Ready or not? Lung cancer diagnosis in 2015.

about

Ready or not? Lung cancer diagnosis in 2015.

Item

http://www.wikidata.org/entity/Q35934215

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Ready or not? Lung cancer diagnosis in 2015.

@ast

Ready or not? Lung cancer diagnosis in 2015.

@en

type

Item

label

Ready or not? Lung cancer diagnosis in 2015.

@ast

Ready or not? Lung cancer diagnosis in 2015.

@en

prefLabel

Ready or not? Lung cancer diagnosis in 2015.

@ast

Ready or not? Lung cancer diagnosis in 2015.

@en

P1476

Ready or not? Lung cancer diagnosis in 2015.

@en

P2093

C Labbe

http://www.w3.org/2001/XMLSchema#string

K Jao

http://www.w3.org/2001/XMLSchema#string

N B Leighl

http://www.w3.org/2001/XMLSchema#string

P2860

Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials

Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.

First-line crizotinib versus chemotherapy in ALK-positive lung cancer.

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma

Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer

Radial probe endobronchial ultrasound for the diagnosis of peripheral lung cancer: systematic review and meta-analysis.

Biomarkers That Currently Affect Clinical Practice in Lung Cancer: EGFR, ALK, MET, ROS-1, and KRAS

Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular

P304

239-242

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.3747/CO.22.2647

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26300660

http://www.w3.org/2001/XMLSchema#string

P932

4530807

http://www.w3.org/2001/XMLSchema#string